Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12801843 | 0.66 | — | — | |
| SCHEMBL6088155 | 0.59 | CYP3A4 (0.38) | POLB | |
| SCHEMBL23025329 | 0.54 | — | — | |
| SCHEMBL470309 | 0.50 | HRH3 (0.56) | — | |
| SCHEMBL25421389 | 0.48 | — | — | |
| SCHEMBL2491769 | 0.46 | ALDH1A1 (0.36) | POLB | |
| SCHEMBL200206 | 0.43 | — | — | |
| SCHEMBL8852783 | 0.43 | ALDH1A1 (0.38) | — | |
| SCHEMBL1585843 | 0.43 | ALDH1A1 (0.42) | POLB | |
| SCHEMBL10748747 | 0.42 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1124826-A1 | PROCESS FOR THE PREPARATION OF 2-(R)-(1- (R)-(3,5-BIS (TRIFLUOROMETHYL) PHENYL)ETHOXY) -4-((5-DIMETHYLAMINOMETHYL) -1,2,3-TRIAZOL -4-YL)METHYL) -3-(S)-(4- FLUOROPHENYL) MORPHOLINE | Merck & Co., Inc. (US) | 2001-08-22 | — | — | EP | claimed |
| WO-2000026215-A1 | PROCESS FOR THE PREPARATION OF 2-(R)-(1- (R)-(3,5-BIS (TRIFLUOROMETHYL) PHENYL)ETHOXY) -4-((5-DIMETHYLAMINOMETHYL) -1,2,3-TRIAZOL -4-YL)METHYL) -3-(S)-(4- FLUOROPHENYL) MORPHOLINE | MERCK & CO., INC. (US) | 2000-05-11 | — | — | WO | claimed |
| US-6051717-A | SUBSTANCE P RECEPTOR ANTAGONIST; POTENTIAL FOR USE IN THE TREATMENT OF INFLAMMATORY DISEASES, EMESIS, DEPRESSION, ANXIETY, AND OTHER NEUROPSYCHIATRIC DISEASES | MERCK & CO., INC. (US) | 2000-04-18 | — | — | US | claimed |
| US-6432952-B1 | CENTRAL NERVOUS SYSTEM DISORDERS; ANTIINFLAMMATORY AGENTS | MERCK & CO., INC. | 2002-08-13 | — | — | US | disclosed |
| EP-1228068-A1 | POLYMORPHIC FORM OF A TACHYKININ RECEPTOR ANTAGONIST | Merck & Co., Inc. (US) | 2002-08-07 | — | — | EP | disclosed |
| EP-1124826-A1 | PROCESS FOR THE PREPARATION OF 2-(R)-(1- (R)-(3,5-BIS (TRIFLUOROMETHYL) PHENYL)ETHOXY) -4-((5-DIMETHYLAMINOMETHYL) -1,2,3-TRIAZOL -4-YL)METHYL) -3-(S)-(4- FLUOROPHENYL) MORPHOLINE | Merck & Co., Inc. (US) | 2001-08-22 | — | — | EP | disclosed |
| WO-2001032656-A1 | POLYMORPHIC FORM OF A TACHYKININ RECEPTOR ANTAGONIST | MERCK & CO., INC. (US) | 2001-05-10 | — | — | WO | disclosed |
| WO-2000026215-A1 | PROCESS FOR THE PREPARATION OF 2-(R)-(1- (R)-(3,5-BIS (TRIFLUOROMETHYL) PHENYL)ETHOXY) -4-((5-DIMETHYLAMINOMETHYL) -1,2,3-TRIAZOL -4-YL)METHYL) -3-(S)-(4- FLUOROPHENYL) MORPHOLINE | MERCK & CO., INC. (US) | 2000-05-11 | — | — | WO | disclosed |
| US-6051717-A | SUBSTANCE P RECEPTOR ANTAGONIST; POTENTIAL FOR USE IN THE TREATMENT OF INFLAMMATORY DISEASES, EMESIS, DEPRESSION, ANXIETY, AND OTHER NEUROPSYCHIATRIC DISEASES | MERCK & CO., INC. (US) | 2000-04-18 | — | — | US | disclosed |
| US-6051717-A | SUBSTANCE P RECEPTOR ANTAGONIST; POTENTIAL FOR USE IN THE TREATMENT OF INFLAMMATORY DISEASES, EMESIS, DEPRESSION, ANXIETY, AND OTHER NEUROPSYCHIATRIC DISEASES | MERCK & CO., INC. (US) | 2000-04-18 | — | — | US | disclosed |